Professional Documents
Culture Documents
CH 11 - Chest Discomfort
CH 11 - Chest Discomfort
CH 11 - Chest Discomfort
Chest discomfort
! among the most common reasons for which patients present for medical attention at either an
emergency department (ED) or an outpatient clinic
! evaluation of nontraumatic chest discomfort
○ inherently challenging owing to the broad variety of possible causes, a minority of which
are life-threatening conditions that should not be missed
! It is helpful to frame the initial diagnostic assessment and triage of patients with acute chest
discomfort around three categories:
○ myocardial ischemia
○ other cardiopulmonary causes
■ pericardial disease, aortic emergencies, and pulmonary conditions
○ non-cardiopulmonary causes
! Although rapid identification of high-risk conditions is a priority of the initial assessment, strategies
that incorporate routine liberal use of testing carry the potential for adverse effects of unnecessary
investigations.
PEACH 2021 4
Physical Examination ELECTROCARDIOGRAPHY
General ! Crucial in the evaluation of nontraumatic chest discomfort
! Patients with acute MI or other acute cardiopulmonary disorders often appear anxious, ! Pivotal for identifying patients with ongoing ischemia as the principal reason for their presentation
uncomfortable, pale, cyanotic, or diaphoretic. as well as secondary cardiac complications of other disorders.
! Patients who are massaging or clutching their chests may describe their pain with a clenched fist ! Professional society guidelines recommend that an ECG be obtained within 10 min of
held against the sternum (Levine’s sign). presentation, with the primary goal of identifying patients with ST-segment elevation diagnostic of
! Occasionally, body habitus is helpful—for example, in patients with Marfan syndrome or the MI who are candidates for immediate interventions to restore flow in the occluded coronary artery
prototypical young, tall, thin man with spontaneous pneumothorax. ! ST-segment depression and symmetric T-wave inversions at least 0.2 mV in depth
Vital Signs ○ Useful for detecting myocardial ischemia in the absence of STEMI and are also indicative
! Significant tachycardia and hypotension of higher risk of death or recurrent ischemia.
○ indicative of important hemodynamic consequences of the underlying cause of chest ! Serial performance of ECGs (every 30–60 min)
discomfort and should prompt a rapid survey for the most severe conditions, such as ○ recommended in the ED evaluation of suspected ACS
acute MI with cardiogenic shock, massive pulmonary embolism, pericarditis with ! In addition, an ECG with right-sided lead placement should be considered in patients with clinically
tamponade, or tension pneumothorax. suspected ischemia and a nondiagnostic standard 12-lead ECG
! Acute aortic emergencies ! Despite the value of the resting ECG, its sensitivity for ischemia is poor—as low as 20% in some
○ usually present with severe hypertension but may be associated with profound studies.
hypotension when there is coronary arterial compromise or dissection into the ! Abnormalities of the ST segment and T wave may occur in a variety of conditions, including:
pericardium. ○ pulmonary embolism
! Sinus tachycardia ○ ventricular hypertrophy
○ important manifestation of submassive pulmonary embolism ○ acute and chronic pericarditis
! Tachypnea and hypoxemia point toward a pulmonary cause ○ myocarditis
! The presence of low-grade fever is non- specific because it may occur with MI and with ○ electrolyte imbalance
thromboembolism in addition to infection ○ metabolic disorders
Pulmonary ! Notably, hyperventilation associated with panic disorder can also lead to nonspecific ST and T-wave
! Examination of the lungs abnormalities
○ may localize a primary pulmonary cause of chest discomfort, as in cases of pneumonia, ! Pulmonary embolism
asthma, or pneumothorax. ○ most often associated with sinus tachycardia
! Left ventricular dysfunction from severe ischemia/infarction as well as acute valvular complications ○ can also lead to rightward shift of the ECG axis, manifesting as an S-wave in lead I, with
of MI or aortic dissection can lead to pulmonary edema, which is an indicator of high risk a Q-wave and T-wave in lead III
Cardiac ! In patients with ST-segment elevation, the presence of diffuse lead involvement not corresponding
! Often normal in patients with acute myocardial ischemia but may reveal characteristic patterns with to a specific coronary anatomic distribution and PR-segment depression can aid in distinguishing
pericardial tamponade or acute right ventricular dysfunction pericarditis from acute MI.
! Cardiac auscultation
○ may reveal a third or, more commonly, a fourth heart sound, reflecting myocardial CHEST RADIOGRAPHY
systolic or diastolic dysfunction ! Plain radiography of the chest
! Murmurs of mitral regurgitation or a ventricular-septal defect ○ performed routinely when patients present with acute chest discomfort and selectively
○ may indicate mechanical complications of STEMI. when individuals who are being evaluated as outpatients have subacute or chronic pain
! A murmur of aortic insufficiency may be a complication of proximal aortic dissection. Other murmurs ! Chest radiograph
may reveal underlying cardiac disorders contributory to ischemia (e.g., aortic stenosis or ○ most useful for identifying pulmonary processes, such as pneumonia or pneumothorax.
hypertrophic cardiomyopathy). ○ Findings are often unremarkable in patients with ACS, but pulmonary edema may be
! Pericardial friction rubs reflect pericardial inflammation. evident
Abdominal ○ Other specific findings include widening of the mediastinum in some patients with aortic
! Localizing tenderness on the abdominal examination dissection, Hampton’s hump or Westermark’s sign in patients with pulmonary embolism
○ useful in identifying a gastrointestinal cause of the presenting syndrome or pericardial calcification in chronic pericarditis.
! Abdominal findings
○ infrequent with purely acute cardiopulmonary problems, except in the case of underlying CARDIAC BIOMARKERS
chronic cardiopulmonary disease or severe right ventricular dysfunction leading to ! Laboratory testing in patients with acute chest pain is focused on the detection of myocardial injury.
hepatic congestion. ! Such injury can be detected by the presence of circulating proteins released from damaged
! Vascular pulse deficits myocardial cells.
○ may reflect underlying chronic atherosclerosis, which increases the likelihood of ! Owing to the time necessary for this release, initial biomarkers of injury may be in the normal range,
coronary artery disease even in patients with STEMI.
! Evidence of acute limb ischemia with loss of the pulse and pallor, particularly in the upper extremities, ! cardiac troponin
can indicate catastrophic consequences of aortic dissection ○ preferred biomarker for the diagnosis of MI and should be measured in all patients with
! Unilateral lower-extremity swelling should raise suspicion about venous thromboembolism. suspected ACS at presentation and repeated in 3–6 h
Musculoskeletal ○ Testing after 6 h is required only when there is uncertainty regarding the onset of pain
! Pain arising from the costochondral and chondrosternal articulations or when stuttering symptoms have occurred.
○ may be associated with localized swelling, redness, or marked localized tenderness ○ It is not necessary or advisable to measure troponin in patients without suspicion of ACS
! Pain on palpation of these joints is usually well localized and is a useful clinical sign, though deep unless this test is being used specifically for risk stratification (e.g., in pulmonary
palpation may elicit pain in the absence of costochondritis. embolism or heart failure).
! Although palpation of the chest wall often elicits pain in patients with various musculoskeletal ! Rapid rule-out protocols that use serial testing and changes in troponin concentration over as short
conditions, it should be appreciated that chest wall tenderness does not exclude myocardial a period as 1–2 h appear promising and have been adopted in some centers where high-sensitivity
ischemia assays for troponin are used routinely.
! Sensory deficits in the upper extremities may be indicative of cervical disk disease.
PEACH 2021 5
! In patients presenting >2 h after symptom onset, a concentration of cardiac troponin below the limit ! Elements common to each of these tools are:
of detection using a high-sensitivity assay may be sufficient to exclude MI with a negative predictive ○ symptoms typical for ACS
value >99% at the time of hospital presentation. ○ older age
! However, with these advantages has come a trade-off: myocardial injury is detected in a larger ○ risk factors for or known atherosclerosis
proportion of patients who have non-ACS cardiopulmonary conditions than with previous, less ○ (4) ischemic ECG abnormalities
sensitive assays. ○ (5) elevated cardiac troponin levels.
! This evolution in testing for myocardial necrosis has rendered other aspects of the clinical evaluation ! Although, because of very low specificity, the overall diagnostic performance of such decision-aids
critical to the practitioner’s determination of the probability that the symptoms represent ACS. is poor (area under the receiver operating curve, 0.55–0.65), they can help identify patients with a
! In addition, observation of a change in cardiac troponin concentration between serial samples is very low probability of ACS (e.g., <1%).
useful in discriminating acute causes of myocardial injury from chronic elevation due to underlying ! Nevertheless, no such decision-aid (or single clinical factor) is sufficiently sensitive and well validated
structural heart disease, end-stage renal disease, or interfering antibodies. to use as a sole tool for clinical decision-making.
! The diagnosis of MI is reserved for acute myocardial injury that is marked by a rising and/or falling ! Clinicians should differentiate between the algorithms discussed above and risk scores derived for
pattern—with at least one value exceeding the 99th percentile reference limit—and that is caused stratification of prognosis in patients who already have an established diagnosis of ACS.
by ischemia. ! The latter risk scores were not designed to be used for diagnostic assessment.
! Other non-ischemic insults, such as myocarditis, may result in myocardial injury but should not be
labeled MI. PROVOCATIVE TESTING FOR ISCHEMIA
! D-dimer test ! Exercise electrocardiography (“stress testing”)
○ to aid in exclusion of pulmonary embolism ○ commonly employed for completion of risk stratification of patients who have undergone
! B-type natriuretic peptide an initial evaluation that has not revealed a specific cause of chest discomfort and has
○ useful when considered in conjunction with the clinical history and examination for the identified them as being at low or selectively inter- mediate risk of ACS.
diagnosis of heart failure ! Early exercise testing
○ provide prognostic information among patients with ACS and those with pulmonary ○ safe in patients without high-risk findings after 8–12 h of observation and can assist in
embolism refin- ing their prognostic assessment.
INTEGRATIVE DECISION AIDS ! Patients who are unable to exercise may undergo pharmacological stress testing with either nuclear
! Multiple clinical algorithms have been developed to aid in decision- making during the evaluation perfusion imaging or echocardiography. Notably, some experts have deemed the routine use of
and disposition of patients with acute nontraumatic chest pain. stress testing for low-risk patients unsupported by direct clinical evidence and a potentially
! Such decision-aids estimate either of two closely related but not identical probabilities: unnecessary source of cost.
○ the probability of a final diagnosis of ACS ! Professional society guidelines identify ongoing chest pain as a contraindication to stress testing.
○ the probability of major cardiac events during short-term follow-up ! In selected patients with persistent pain and nondiagnostic ECG and biomarker data, resting
! Such decision-aids are used most commonly to identify patients with a low clinical probability of ACS myocardial perfusion images can be obtained
who are candidates either for early provocative testing for ischemia or for discharge from the ED. ○ the absence of any perfusion abnormality substantially reduces the likelihood of coronary
! Goldman and Lee developed one of the first such decision-aids artery disease
○ using only the ECG and risk indicators— hypotension, pulmonary rales, and known ! In some centers, early myocardial perfusion imaging is performed as part of a routine strategy for
ische- mic heart disease—to categorize patients into four risk categories ranging from a evaluating patients at low or intermediate risk of ACS in parallel with other testing.
<1% to a >16% probability of a major cardiovascular complication ! Management of patients with normal perfusion images can be expedited with earlier discharge and
! Acute Cardiac Ischemia Time-Insensitive Predic- tive Instrument (ACI-TIPI) outpatient stress testing, if indicated. Those with abnormal rest perfusion imaging, which cannot
○ combines age, sex, chest pain presence, and ST-segment abnormalities to define a discriminate between old or new myocardial defects, usually warrant additional in-hospital
probability of ACS. evaluation.
! More recently developed decision-aids are shown in Fig. 11-3.
OTHER NONINVASIVE STUDIES
Echocardiography
! Not necessarily routine in patients with chest discomfort
! However, in patients with an uncertain diagnosis, particularly those with nondiagnostic ST elevation,
ongoing symptoms, or hemodynamic instability, detection of abnormal regional wall motion provides
evidence of possible ischemic dysfunction.
! Diagnostic in patients with mechanical complications of MI or in patients with pericardial tamponade.
! Transthoracic echocardiography is poorly sensitive for aortic dissection, although an intimal flap may
sometimes be detected in the ascending aorta.
CT Angiography
! Emerging as a modality for the evaluation of patients with acute chest discomfort
! Coronary CT angiography
○ sensitive technique for detection of obstructive coronary disease, particularly in the
proximal third of the major epicardial coronary arteries
○ appears to enhance the speed to disposition of patients with a low-intermediate
probability for ACS
○ its major strength being the negative predictive value of a finding of no significant
disease.
! In addition, contrast-enhanced CT can detect focal areas of myocardial injury in the acute setting.
! At the same time, CT angiography can exclude aortic dissection, pericardial effusion, and pulmonary
embolism.
! Balancing factors in the consideration of the emerging role of coronary CT angiography in low-risk
patients are radiation exposure and additional testing prompted by nondiagnostic abnormal results.
PEACH 2021 6
MRI
! evolving, versatile technique for structural and functional evaluation of the heart and the vasculature
of the chest
! can be performed as a modality for pharmacologic stress perfusion imaging
! Gadolinium-enhanced CMR
○ can provide early detection of MI, defining areas of myocardial necrosis accurately, and
can delineate patterns of myocardial disease that are often useful in discriminating
ischemic from non-ischemic myocardial injury
! Usually not practical for the urgent evaluation of acute chest discomfort
! Can be a useful modality for cardiac structural evaluation of patients with elevated cardiac troponin
levels in the absence of definite coronary artery disease
! Also permits highly accurate assessment for aortic dissection but is infrequently used as the first test
because CT and transesophageal echocardiography are usually more practical.
PEACH 2021 7